Principal Financial Group Inc Agios Pharmaceuticals, Inc. Transaction History

Principal Financial Group Inc

  • $160 Billion
  • Q2 2024

A detailed history of Principal Financial Group Inc transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 7,594 shares of AGIO stock, worth $354,563. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,594
Previous 13,431 43.46%
Holding current value
$354,563
Previous $392,000 16.58%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024
SELL
$27.55 - $48.83 $160,809 - $285,020
-5,837 Reduced 43.46%
7,594 $327,000
Q1 2024

Apr 29, 2024
SELL
$21.32 - $34.81 $26,180 - $42,746
-1,228 Reduced 8.38%
13,431 $392,000
Q4 2023

Feb 07, 2024
SELL
$19.97 - $24.53 $30,534 - $37,506
-1,529 Reduced 9.45%
14,659 $326,000
Q3 2023

Nov 02, 2023
BUY
$24.36 - $28.18 $63,555 - $73,521
2,609 Added 19.21%
16,188 $400,000
Q2 2023

Aug 07, 2023
SELL
$21.38 - $29.19 $15,671 - $21,396
-733 Reduced 5.12%
13,579 $384,000
Q1 2023

May 09, 2023
BUY
$21.74 - $30.93 $52,175 - $74,232
2,400 Added 20.15%
14,312 $328,000
Q4 2022

Feb 09, 2023
SELL
$24.81 - $31.52 $307,122 - $390,186
-12,379 Reduced 50.96%
11,912 $334,000
Q3 2022

Nov 09, 2022
SELL
$19.51 - $34.14 $363,354 - $635,823
-18,624 Reduced 43.4%
24,291 $687,000
Q2 2022

Aug 10, 2022
SELL
$17.06 - $31.42 $490,952 - $904,204
-28,778 Reduced 40.14%
42,915 $951,000
Q1 2022

May 09, 2022
SELL
$26.68 - $34.81 $777,081 - $1.01 Million
-29,126 Reduced 28.89%
71,693 $2.09 Million
Q4 2021

Feb 09, 2022
SELL
$29.58 - $49.78 $326,977 - $550,268
-11,054 Reduced 9.88%
100,819 $3.31 Million
Q3 2021

Nov 09, 2021
SELL
$41.92 - $58.18 $195,766 - $271,700
-4,670 Reduced 4.01%
111,873 $5.16 Million
Q2 2021

Aug 10, 2021
BUY
$52.06 - $61.27 $537,259 - $632,306
10,320 Added 9.72%
116,543 $6.42 Million
Q1 2021

May 10, 2021
BUY
$44.23 - $57.5 $629,039 - $817,765
14,222 Added 15.46%
106,223 $5.49 Million
Q4 2020

Feb 08, 2021
BUY
$33.21 - $46.54 $2.57 Million - $3.61 Million
77,466 Added 532.96%
92,001 $3.99 Million
Q3 2020

Nov 06, 2020
SELL
$33.87 - $55.93 $195,937 - $323,555
-5,785 Reduced 28.47%
14,535 $508,000
Q2 2020

Aug 05, 2020
BUY
$34.45 - $53.48 $182,653 - $283,550
5,302 Added 35.3%
20,320 $1.09 Million
Q1 2020

May 12, 2020
BUY
$31.52 - $53.81 $49,328 - $84,212
1,565 Added 11.63%
15,018 $533,000
Q4 2019

Feb 05, 2020
BUY
$30.08 - $50.59 $132,231 - $222,393
4,396 Added 48.54%
13,453 $643,000
Q3 2019

Nov 13, 2019
SELL
$32.4 - $49.58 $142,398 - $217,904
-4,395 Reduced 32.67%
9,057 $293,000
Q2 2019

Aug 12, 2019
SELL
$46.17 - $68.1 $68,008 - $100,311
-1,473 Reduced 9.87%
13,452 $671,000
Q1 2019

May 10, 2019
BUY
$45.92 - $67.67 $54,828 - $80,797
1,194 Added 8.7%
14,925 $1.01 Million
Q4 2018

Feb 14, 2019
SELL
$42.73 - $76.53 $91,869 - $164,539
-2,150 Reduced 13.54%
13,731 $633,000
Q3 2018

Nov 14, 2018
BUY
$71.67 - $91.95 $45,367 - $58,204
633 Added 4.15%
15,881 $1.23 Million
Q2 2018

Aug 13, 2018
BUY
$73.22 - $99.55 $25,846 - $35,141
353 Added 2.37%
15,248 $0
Q1 2018

May 14, 2018
BUY
$59.83 - $86.53 $91,719 - $132,650
1,533 Added 11.47%
14,895 $1.22 Million
Q4 2017

Feb 13, 2018
BUY
$52.12 - $72.33 $400,229 - $555,422
7,679 Added 135.12%
13,362 $764,000
Q3 2017

Nov 02, 2017
BUY
$54.89 - $67.12 $311,939 - $381,442
5,683
5,683 $379,000

Others Institutions Holding AGIO

# of Institutions
226
Shares Held
56.3M
Call Options Held
275K
Put Options Held
251K
View Full List

About AGIOS PHARMACEUTICALS, INC.

AGIO Quotes by TradingView
  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $2.56B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email